Reiko Kamei

Datopotamab Deruxtecan, a Novel TROP2-directed Antibody–drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells

M. Yamaguchi, M. Murakami, H. Hamada, 2021, Molecular Cancer Therapeutics.

Identification and Therapeutic Targeting of GPR20, Selectively Expressed in Gastrointestinal Stromal Tumors, with DS-6157a, a First-In-Class Antibody-Drug Conjugate.

G. Demetri, A. Ochiai, S. George, 2021, Cancer discovery.

G protein‐coupled receptor 39 plays an anti‐inflammatory role by enhancing IL‐10 production from macrophages under inflammatory conditions

Y. Tomimori, Reiko Kamei, M. Goto, 2018, European journal of pharmacology.

Abstract 5181: Therapeutic targeting of GPR20, selectively expressed in gastrointestinal stromal tumor (GIST), with DS-6157a, an antibody-drug conjugate (ADC)

G. Demetri, A. Ochiai, S. George, 2020 .